PT3344758T - Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos - Google Patents

Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos

Info

Publication number
PT3344758T
PT3344758T PT167670447T PT16767044T PT3344758T PT 3344758 T PT3344758 T PT 3344758T PT 167670447 T PT167670447 T PT 167670447T PT 16767044 T PT16767044 T PT 16767044T PT 3344758 T PT3344758 T PT 3344758T
Authority
PT
Portugal
Prior art keywords
population
cells
pluripotents
differentiation
human
Prior art date
Application number
PT167670447T
Other languages
English (en)
Original Assignee
Ncardia B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ncardia B V filed Critical Ncardia B V
Publication of PT3344758T publication Critical patent/PT3344758T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/375—Thyroid stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT167670447T 2015-09-01 2016-08-31 Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos PT3344758T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2015385 2015-09-01

Publications (1)

Publication Number Publication Date
PT3344758T true PT3344758T (pt) 2021-10-28

Family

ID=56117922

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167670447T PT3344758T (pt) 2015-09-01 2016-08-31 Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos

Country Status (8)

Country Link
US (2) US11136551B2 (pt)
EP (2) EP3344758B1 (pt)
DK (1) DK3344758T3 (pt)
ES (1) ES2895676T3 (pt)
HU (1) HUE057135T2 (pt)
PL (1) PL3344758T3 (pt)
PT (1) PT3344758T (pt)
WO (1) WO2017039445A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1248270A1 (zh) 2015-02-17 2018-10-12 大学健康网路 制备和使用窦房结样起搏器心肌细胞和心室样心肌细胞的方法
NL2019618B1 (en) 2017-09-22 2019-03-28 Ncardia B V In vitro method for providing stem cell derived cardiomyocytes
CN108913655B (zh) * 2018-07-16 2022-07-15 浙江大学 基于多能干细胞技术建立“人源性”心肌肥大模型的方法
CA3109078A1 (en) * 2018-07-17 2020-01-23 The Regents Of The University Of California Cells differentiated from immunoengineered pluripotent cells
CA3139072A1 (en) 2019-05-03 2020-11-12 University Health Network Cardiomyocyte compositions and use thereof
US11162079B2 (en) 2019-05-10 2021-11-02 The Regents Of The University Of California Blood type O Rh-hypo-immunogenic pluripotent cells
US12221622B2 (en) 2019-05-10 2025-02-11 The Regents Of The University Of California Modified pluripotent cells
WO2023087109A1 (en) * 2021-11-17 2023-05-25 The Governing Council Of The University Of Toronto Maturation medium for pluripotent stem cell-derived cardiomyocytes
KR20240142624A (ko) * 2022-01-10 2024-09-30 사나 바이오테크놀로지, 인크. 만능줄기세포에서 분화된 면역저하 베타세포 및 관련 용도 및 방법
JPWO2024004960A1 (pt) * 2022-06-27 2024-01-04

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE116335T1 (de) 1987-12-24 1995-01-15 Gropep Pty Ltd Peptid-analoge vom insulinähnlichen wachstums- faktor 1 (igf-1) oder faktor 2 (igf-2).
WO1990015142A1 (en) 1989-06-09 1990-12-13 Gropep Pty. Ltd. Growth hormone fusion proteins
CA3022238A1 (en) * 2005-08-19 2007-02-22 Duke University Stem cell derived factors for treating pathologic conditions
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
UA103918C2 (en) 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
JP5902092B2 (ja) 2009-10-19 2016-04-13 セルラー ダイナミクス インターナショナル， インコーポレイテッド 心筋細胞の生成
EP2610249B1 (en) 2010-08-26 2017-10-11 Kyoto University Pluripotent stem cell cardiomyocyte differentiation-promoting agent
RU2618871C2 (ru) 2011-06-09 2017-05-11 Ф. Хоффманн-Ля Рош Аг Способ дифференциации плюрипотентных стволовых клеток в клетки сосудистого русла
US9034584B2 (en) 2011-07-29 2015-05-19 Cellular Dynamics International, Inc. Metabolic maturation in stem cell-derived tissue cells
US8951798B2 (en) * 2011-10-13 2015-02-10 Wisconsin Alumni Research Foundation Generation of cardiomyocytes from human pluripotent stem cells
WO2014078414A1 (en) * 2012-11-13 2014-05-22 Joseph Wu Chemically defined production of cardiomyocytes from pluripotent stem cells
US9783550B2 (en) 2013-05-14 2017-10-10 The Board Of Regents Of The University Of Texas System Highly potent inhibitors of porcupine
ES2806698T3 (es) 2013-06-11 2021-02-18 Ncardia B V Composiciones de medio de cultivo para la maduración de cardiomiocitos derivados de células madre pluripotentes de mamíferos
DK3017038T3 (da) 2013-07-02 2019-08-19 Nat Univ Singapore Differentiering af pluripotente stamceller og hjerteprogenitorceller i tværstribede kardiomyocytfibre under anvendelse af lamininer ln-511, ln-521 og ln-221
JP6681825B2 (ja) * 2013-09-20 2020-04-15 レパイロン・ゲーエムベーハーＲｅｐａｉｒｏｎ Ｇｍｂｈ 多能性幹細胞から機能的心筋へと直接分化させる方法

Also Published As

Publication number Publication date
US11136551B2 (en) 2021-10-05
EP3964565A1 (en) 2022-03-09
DK3344758T3 (da) 2021-11-01
US20220025333A1 (en) 2022-01-27
PL3344758T3 (pl) 2022-01-03
WO2017039445A1 (en) 2017-03-09
EP3344758B1 (en) 2021-09-29
EP3344758A1 (en) 2018-07-11
US20180251734A1 (en) 2018-09-06
HUE057135T2 (hu) 2022-04-28
EP3964565B1 (en) 2026-04-08
ES2895676T3 (es) 2022-02-22

Similar Documents

Publication Publication Date Title
PT3344758T (pt) Um método in vitro para diferenciação de uma população de células estaminais pluripotentes humanas numa população de células de cardiomiócitos
SG11201705750WA (en) Method for inducing differentiation of corneal epithelial cells from pluripotent stem cells
IL287558A (en) Method of screening for agents for differentiating stem cells
PT3303564T (pt) Métodos de diferenciação in vitro de neurónios de dopamina de mesencéfalo (mda)
PT3708668T (pt) Moléculas de ácido nucleico artificiais para uma expressão melhorada de proteína
BR112016028285A2 (pt) métodos para colheita de culturas de células de mamíferos
IL257170B (en) Stable proteins and methods for designing same
EP2968673A4 (en) Decellulization process of tissue transports
HUE053271T2 (hu) Szérumfoszfát hatásos és hatékony szabályozása az optimális csontképzõdésért
SG11201708741YA (en) Compositions and methods for biological production of methionine
SG11201609091YA (en) Method for assessing state of differentiation of cells
EP3366779A4 (en) EVALUATION METHOD FOR DIFFERENTIATING THE CONDITION OF CELLS
EP3196298A4 (en) Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel
EP3372681A4 (en) IMMORTALIZED STEM CELLS AND METHOD FOR THE MANUFACTURE THEREOF
EP3530237A4 (en) STEM FOR ARTIFICIAL HIP JOINT AND STEM PROCESSING PROCESS
EP3324533A4 (en) ELECTROSTATIC ACTUATOR AND METHOD FOR PRODUCING THE ELECTROSTATIC ACTUATOR
EP3147356A4 (en) Method for inducing differentiation of insulin-producing cells
EP3334384A4 (en) SHOULDER JOINT PROSTHESIS MINE
DK3500859T3 (da) Markør for neurale stamceller
IL263557B (en) Differentiation of pluripotent stem cells into iris cells
IL247629B (en) Electrolyte charging and replacement station and method for operating it
EP3476749A4 (en) ARTIFICIAL SATELLITE AND METHOD FOR ADJUSTING THE SHIFT COMPENSATION
EP3495471A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN VITRO
EP3354722A4 (en) METHOD FOR CONTROLLING THE DIFFERENTIATION OF STEM CELLS
EP3540049A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENTAL STEM CELLS IN SOMATIC CELLS